Experienced in Allergic Conjunctivitis

Dr. Amy L. Darter

Allergy and Immunology
1810 E Memorial Rd, 
Oklahoma City, OK 
Experienced in Allergic Conjunctivitis
1810 E Memorial Rd, 
Oklahoma City, OK 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Amy Darter is an Allergy and Immunologist in Oklahoma City, Oklahoma. Dr. Darter is rated as an Experienced provider by MediFind in the treatment of Allergic Conjunctivitis. Her top areas of expertise are Primary Immunodeficiency (PID), Grass Allergy, Allergic Rhinitis, and X-Linked Agammaglobulinemia.

Her clinical research consists of co-authoring 5 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Allergy and Immunology
Licenses
Allergy & Immunology in OK
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

1810 E Memorial Rd, Oklahoma City, OK 73131

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

An Open-Label, Single-Arm, Historically Controlled, Prospective, Multi-Center Phase III Study to Evaluate the Pharmacokinetics and Safety of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency
An Open-Label, Single-Arm, Historically Controlled, Prospective, Multi-Center Phase III Study to Evaluate the Pharmacokinetics and Safety of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency
Enrollment Status: Active_not_recruiting
Publish Date: July 25, 2025
Intervention Type: Biological
Study Phase: Phase 3
Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric Subjects With Primary Immunodeficiency Diseases
Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric Subjects With Primary Immunodeficiency Diseases
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Biological
Study Phase: Phase 3
A Multi-center, Single-Sequence, Open-label Study to Evaluate IGSC 20% Biweekly Dosing in Treatment-Experienced Subjects and Loading/Maintenance Dosing in Treatment-Naïve Subjects With Primary Immunodeficiency
A Multi-center, Single-Sequence, Open-label Study to Evaluate IGSC 20% Biweekly Dosing in Treatment-Experienced Subjects and Loading/Maintenance Dosing in Treatment-Naïve Subjects With Primary Immunodeficiency
Enrollment Status: Completed
Publish Date: September 29, 2023
Intervention Type: Biological
Study Phase: Phase 4
A Phase 3, Multicenter, Open-label, Single-sequence, Cross-over, Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of IVIG-PEG Compared to Gamunex-C in Subjects With Primary Humoral Immunodeficiency
A Phase 3, Multicenter, Open-label, Single-sequence, Cross-over, Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of IVIG-PEG Compared to Gamunex-C in Subjects With Primary Humoral Immunodeficiency
Enrollment Status: Completed
Publish Date: June 05, 2023
Intervention Type: Biological
Study Phase: Phase 3
An Open-Label, Single-Arm, Historically Controlled, Prospective, Multicenter Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
An Open-Label, Single-Arm, Historically Controlled, Prospective, Multicenter Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
Enrollment Status: Completed
Publish Date: December 09, 2022
Intervention Type: Biological
Study Phase: Phase 3
View 4 Less Clinical Trials

5 Total Publications

Towards an FDA-cleared basophil activation test.
Towards an FDA-cleared basophil activation test.
Journal: Frontiers in allergy
Published: August 01, 2022
Similar Doctors
Tim D. Trojan
Advanced in Allergic Conjunctivitis
Dr. Tim D. Trojan
Allergy and Immunology
Advanced in Allergic Conjunctivitis
Dr. Tim D. Trojan
Allergy and Immunology

Allergy Partners Of Oklahoma - Enid

3201 North Van Buren Street, 
Enid, OK 
 (61.0 miles away)
580-366-0844
Languages Spoken:
English
See accepted insurances

Tim Trojan is an Allergy and Immunologist in Enid, Oklahoma. Dr. Trojan is rated as a Distinguished provider by MediFind in the treatment of Allergic Conjunctivitis. His top areas of expertise are Grass Allergy, Sinusitis, Allergic Rhinitis, and Hives.

Advanced in Allergic Conjunctivitis
Dr. Dean A. Atkinson
Allergy and Immunology
Advanced in Allergic Conjunctivitis
Dr. Dean A. Atkinson
Allergy and Immunology

Oklahoma Allergy And Asthma Clinic

3560 S. Boulevard St. Ste 150, 
Edmond, OK 
 (0.7 miles away)
405-235-0040
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dean Atkinson is an Allergy and Immunologist in Edmond, Oklahoma. Dr. Atkinson is rated as an Advanced provider by MediFind in the treatment of Allergic Conjunctivitis. His top areas of expertise are Grass Allergy, Allergic Rhinitis, Sinusitis, and Allergic Conjunctivitis. Dr. Atkinson is currently accepting new patients.

Experienced in Allergic Conjunctivitis
Dr. Richard T. Hatch
Allergy and Immunology | Pediatrics
Experienced in Allergic Conjunctivitis
Dr. Richard T. Hatch
Allergy and Immunology | Pediatrics

Oklahoma Allergy And Asthma Clinic

3560 S. Boulevard St. Ste 150, 
Edmond, OK 
 (0.7 miles away)
405-235-0040
Languages Spoken:
English, Spanish, Vietnamese
See accepted insurances
Accepting New Patients
Offers Telehealth

Richard Hatch is an Allergy and Immunologist and a Pediatrics provider in Edmond, Oklahoma. Dr. Hatch is rated as an Advanced provider by MediFind in the treatment of Allergic Conjunctivitis. His top areas of expertise are Grass Allergy, Allergic Rhinitis, Sinusitis, and Allergic Conjunctivitis. Dr. Hatch is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Darter's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile